Welcome to our dedicated page for Knife River Corporation news (Ticker: $KNF), a resource for investors and traders seeking the latest updates and insights on Knife River Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Knife River Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Knife River Corporation's position in the market.
Knife River (NYSE: KNF) reported record revenue and increased backlog at higher margins for the first quarter of 2024. The company achieved revenue of $329.6 million, a 7% increase from the prior year, with gross profit growing by 59%. Knife River's net loss margin was 14.5%, while Adjusted EBITDA margin stood at 5.4%. The company continues to focus on organic and acquisition growth, with a strong pipeline of deals. Despite a seasonal net loss, Knife River reaffirmed its 2024 guidance, projecting mid-to-high single-digit price growth and flat to low-single-digit volume declines.
